US Patent Issued to Chugai Seiyaku on Oct. 14 for "Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient" (Japanese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,804, issued on Oct. 14, was assigned to Chugai Seiyaku K.K. (Tokyo).

"Pharmaceutical composition for prevention and/or treatment of atopic dermatitis comprising IL-31 antagonist as active ingredient" was invented by Akihisa Kaneko (Shizuoka, Japan), Yuki Iwayanagi (Shizuoka, Japan), Hidetomo Kitamura (Shizuoka, Japan), Yoshinobu Higuchi (Shizuoka, Japan), Hiroaki Matsushita (Shizuoka, Japan), Ryosuke Mihara (Tokyo), Yumi Yamamoto (Tokyo), Tomohisa Saito (Tokyo) and Keiko Hirokawa (Tokyo).

According to the abstract* released by the U.S. Patent & Trademark Office: "In a non-limiting embodiment, there is provided a pharmaceutical composition for prevention and/or treatment of atopic...